cnbc.com / .cnbc-com-health-care

A closely watched pill from Novo Nordisk just scored an approval for slashing cardiovascular risks, while Mark Cuban gives Trump credit on drug prices.

President Trump floated idea of importing Argentine beef after bailout, but U.S. cattleman say it's market manipulation, not a solution to stressed food supply.

Novo Nordisk directors and the firm's controlling shareholder failed to reach an agreement on the future composition of the board.

The announcement marks Anthropic's first formal launch within the life sciences sector ...

Eli Lilly and Novo Nordisk shares dropped after President Donald Trump said he wants a $150 price tag for GLP-1s.

The procedure is often not fully covered by insurance -- if covered at all -- and the costs for accessing it can cost around $20,000 or more per cycle.

The program will sell Xofluza through three pharmacies with a $50 cash pay option, which is 70% lower than the pill's current list price before insurance.

The new DuPont will focus on four key markets: health care, water, and diversified industrials.

Speaking at CNBC's Invest in America Forum, the CEOs said the U.S. still leads in many sectors, but inconsistent policy and underinvestment is ceding ground.

We're debating if it's time to ring the register on Abbott and free up a space in the portfolio for a new name.